Skip to main content
Duluc, L., Ahmetaj-Shala, B., Mitchell, J., Abdul-Salam, V. B., Mahomed, A. S., Aldabbous, L., Oliver, E., Iannone, L., Dubois, O. D., Storck, E. M., Tate, E. W., Zhao, L., Wilkins, M. R., & Wojciak-Stothard, B.
[2017]. Tipifarnib prevents development of hypoxia-induced pulmonary hypertension. Cardiovascular research, 113(3), 276–287.
*Montó, F., *Oliver, E., Vicente, D., Buendía, F., Rueda, J., Agüero, J., Almenar, L., Valldecabres, C., Rovira, E., Muedra, V., Noguera, M. A., Ivorra, M. D., & DʼOcon, P. (*co-first authors).
[2015]. β2- and β1-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases. Journal of cardiovascular pharmacology, 66(5), 478–486.
*Zhao, L., *Oliver, E., Maratou, K., Atanur, S. S., Dubois, O. D., Cotroneo, E., Chen, C. N., Wang, L., Arce, C., Chabosseau, P. L., Ponsa-Cobas, J., Frid, M. G., Moyon, B., Webster, Z., Aldashev, A., Ferrer, J., Rutter, G. A., Stenmark, K. R., Aitman, T. J., & Wilkins, M. R. (*co-first authors).
[2015]. The zinc transporter ZIP12 regulates the pulmonary vascular response to chronic hypoxia. Nature, 524(7565), 356–360.
Lambden, S., Kelly, P., Ahmetaj-Shala, B., Wang, Z., Lee, B., Nandi, M., Torondel, B., Delahaye, M., Dowsett, L., Piper, S., Tomlinson, J., Caplin, B., Colman, L., Boruc, O., Slaviero, A., Zhao, L., Oliver, E., Khadayate, S., Singer, M., Arrigoni, F., … Leiper, J.
[2015]. Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis. Arteriosclerosis, thrombosis, and vascular biology, 35(6), 1382–1392.
Oliver, E., Flacco, N., Arce, C., Ivorra, M. D., D'Ocon, M. P., & Noguera, M. A.
[2014]. Changes in adrenoceptors and G-protein-coupled receptor kinase 2 in L-NAME-induced hypertension compared to spontaneous hypertension in rats. Journal of vascular research, 51(3), 209–220.
George, P. M., Oliver, E., Dorfmuller, P., Dubois, O. D., Reed, D. M., Kirkby, N. S., Mohamed, N. A., Perros, F., Antigny, F., Fadel, E., Schreiber, B. E., Holmes, A. M., Southwood, M., Hagan, G., Wort, S. J., Bartlett, N., Morrell, N. W., Coghlan, J. G., Humbert, M., Zhao, L., Mitchell, J. A.
[2014]. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circulation research, 114(4), 677–688.
Vicente, D., Montó, F., Oliver, E., Buendía, F., Rueda, J., Agüero, J., Almenar, L., Barettino, D., & D'Ocon, P.
[2013]. Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status. Life sciences, 93(2-3), 108–115.
Watson, G., Oliver, E., Zhao, L., & Wilkins, M. R.
[2013]. Pulmonary hypertension: old targets revisited (statins, PPARs, beta-blockers). Handbook of experimental pharmacology, 218, 531–548.
Zhao, L., Chen, C. N., Hajji, N., Oliver, E., Cotroneo, E., Wharton, J., Wilkins, M. R., Wang, D., Li, M., Stenmark, K. R., McKinsey, T. A., & Buttrick, P.
[2013]. Response to letter regarding article, “histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid”. Circulation, 127(14), e540.
Montó, F., Oliver, E., Vicente, D., Rueda, J., Agüero, J., Almenar, L., Ivorra, M. D., Barettino, D., & D'Ocon, P.
[2012]. Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables. American journal of physiology. Heart and circulatory physiology, 303(3), H368–H376.
Zhao, L., Chen, C. N., Hajji, N., Oliver, E., Cotroneo, E., Wharton, J., Wang, D., Li, M., McKinsey, T. A., Stenmark, K. R., & Wilkins, M. R.
[2012]. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation, 126(4), 455–467.
Wojciak-Stothard, B., Zhao, L., Oliver, E., Dubois, O., Wu, Y., Kardassis, D., Vasilaki, E., Huang, M., Mitchell, J. A., Harrington, L. S., Prendergast, G. C., & Wilkins, M. R.
[2012]. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia. Circulation research, 110(11), 1423–1434.
Martínez-Revelles, S., Caracuel, L., Márquez-Martín, A., Dantas, A., Oliver, E., D'Ocon, P., & Vila, E.
[2012]. Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion. British journal of pharmacology, 165(4), 937–950.
Agüero, J., Almenar, L., Montó, F., Oliver, E., Sánchez-Lázaro, I., Vicente, D., Martínez-Dolz, L., D'Ocon, P., Rueda, J., & Salvador, A.
[2012]. Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure. Journal of cardiac failure, 18(1), 53–61.
Oliver E.
[2011]. Pulmonary Hypertension in Children: The First Book Written in Spanish. PVRI Review. 3(2):119.
Segura, V., Flacco, N., Oliver, E., Barettino, D., D'Ocon, P., & Ivorra, M. D.
[2010]. Alpha1-adrenoceptors in the rat cerebral cortex: new insights into the characterization of alpha1L- and alpha1D-adrenoceptors. European journal of pharmacology, 641(1), 41–48.
Oliver, E., Rovira, E., Montó, F., Valldecabres, C., Julve, R., Muedra, V., Ruiz, N., Barettino, D., & D'Ocon, P.
[2010]. beta-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion. Journal of hypertension, 28(6), 1281–1289.
Agüero, J., Almenar, L., D'Ocon, P., Oliver, E., Montó, F., Rueda, J., Vicente, D., Martínez-Dolz, L., & Salvador, A.
[2009]. Myocardial and peripheral lymphocytic transcriptomic dissociation of beta-adrenoceptors and G protein-coupled receptor kinases in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society
Oliver, E., Martí, D., Montó, F., Flacco, N., Moreno, L., Barettino, D., Ivorra, M. D., & D'Ocon, P.
[2009]. The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension. The Journal of pharmacology and experimental therapeutics, 328(3), 982–990.